SCHEMBL19085578

SCHEMBL19085578

CN/C(=N/N)NN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11724976 1.00
SCHEMBL13876328 0.83
Hydrochloric Acid SCHEMBL9499969 0.80
Iodide SCHEMBL2901457 0.80
SCHEMBL333368 0.79
Hydrochloric Acid SCHEMBL9509466 0.76
SCHEMBL13985111 0.75
Hydrochloric Acid SCHEMBL29043673 0.73
Iodide SCHEMBL11304158 0.73
Iodide SCHEMBL11304155 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024129763-A1 MODULATORS OF TNF-α ACTIVITY FORWARD THERAPEUTICS, INC. (US) 2024-06-20 WO disclosed
EP-4159723-A1 NOVEL THYROID HORMONE ß RECEPTOR AGONIST Chengdu Kanghong Pharmaceutical Co., Ltd. (CN) 2023-04-05 EP disclosed
EP-3617221-A1 CYTOTOXIN AND CONJUGATE, USES OF SAME, AND PREPARATION METHOD THEREFOR Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2020-03-04 EP disclosed
WO-2017117239-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS FLATLEY DISCOVERY LAB, LLC (US) 2017-07-06 WO disclosed